Gabelli Funds’s Lifecore Biomedical LFCR Stock Holding History
Bought
Maintained
Sold
Other funds holding LFCR
Gabelli Funds's LFCR Position: Q3 2026 in Review
Gabelli Funds held its Lifecore Biomedical (LFCR) position steady in Q3 2026 at 13,500 shares worth $88.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1209.
Gabelli Funds first reported a position in LFCR in Q4 2020 and has held it in 24 quarters since. The position peaked at $439K in Q2 2021. 105 funds tracked by Wall St. Rank hold LFCR as of Q3 2026.
- Gabelli Funds held 13,500 shares of Lifecore Biomedical worth $88.8K as of Q3 2026.
- Gabelli Funds left its Lifecore Biomedical share count unchanged in Q3 2026.
- Lifecore Biomedical made up ﹤0.01% of Gabelli Funds's portfolio in Q3 2026, its #1209 holding.
- Gabelli Funds first reported a position in Lifecore Biomedical in Q4 2020 and has held it in 24 quarters since.
- Gabelli Funds's Lifecore Biomedical position peaked at $439K in Q2 2021.
- 105 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q3 2026.
Based on Gabelli Funds's 13F filing for Q3 2026, filed 12 Nov 2026.